Adenovirus Type 4 and Type 7 Vaccine (Live, Oral)

4型和7型腺病毒疫苗(口服活疫苗)

Report date: 2025/01/06 10:23:06

Base Information

Drug NameAdenovirus Type 4 and Type 7 Vaccine (Live, Oral)
Drug Alias NameDR-5001
ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiration DisordersRespiratory Tract DiseasesAdenoviridae Infections
Global Approved IndicationsRespiration DisordersAdenoviridae Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2011/03/16
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBarr Labs
China Registration ClassN/A

Develop Information

Active CompaniesBarr Labs
Inactive CompaniesDuramed Research, Inc
Active IndicationsRespiration DisordersAdenoviridae Infections
Inactive IndicationsRespiratory Tract Diseases

Other Information

ATC CodeJ07BX
Related LinksN/A